Cytomyx

Cytomyx was a biotechnology company specializing in the development and provision of ion channel cell lines and related drug discovery services. Based in Cambridge, UK, the company offered a comprehensive portfolio of validated cell lines expressing various ion channels, including sodium, potassium, and calcium channels, to support pharmaceutical and biotech research. Their products were primarily used in high-throughput screening and safety pharmacology, particularly for hERG testing to assess cardiac toxicity. In 2005, Cytomyx was acquired by Millipore Corporation for approximately $5.4 million to enhance its drug discovery capabilities. The company's expertise in electrophysiology and cell line engineering made it a key player in the ion channel research tools market.